Lista de obras - Ian Chau - Dominio Público Uruguay

A very rare complication of subdural haematoma: fibrin-associated diffuse large B-cell lymphoma

artículo científico publicado en 2020

ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UK

scientific article published on 11 July 2019

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study

artículo científico publicado en 2021

Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study

article published in 2018

Association of quality of life with disease characteristics and treatment outcomes in patients with advanced gastric cancer: Exploratory analysis of RAINBOW and REGARD phase III trials

scientific article published on 14 December 2018

Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases ⬇️

artículo científico publicado el 13 de diciembre de 2011

Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer

artículo científico publicado en 2020

Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer.

artículo científico publicado en 2009

Evaluating Mesorectal Lymph Nodes in Rectal Cancer Before and After Neoadjuvant Chemoradiation Using Thin-Section T2-Weighted Magnetic Resonance Imaging

Exclusion of Gastrointestinal Cancer Patients With Prior Cancer From Clinical Trials: Is This Justified?

artículo científico publicado en 2015

In Reply

Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: A pooled analysis of four randomised trials

artículo científico publicado en 2019

Integrative molecular analysis of colorectal cancer and gastric cancer: What have we learnt?

scientific article published on 21 December 2018

Is front-line checkpoint blockade ATTRACTIVE in advanced gastric cancer?

scientific article published on 01 February 2019

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer.

artículo científico publicado en 2018

Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer

artículo científico publicado en 2017

Molecular target: pan-AKT in gastric cancer

scientific article published on 01 September 2020

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

article by Alice Dewdney et al published 10 May 2012 in Journal of Clinical Oncology

Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial

artículo científico publicado en 2010

Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer

artículo científico publicado en 2006

Neoadjuvant chemotherapy alone for early-stage rectal cancer: an evolving paradigm?

artículo científico publicado en 2011

Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers

artículo científico publicado en 2020

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.

artículo científico publicado en 2018

Patupilone in cancer treatment ⬇️

artículo científico publicado el 11 de diciembre de 2010

Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-cell Lymphoma

artículo científico publicado en 2020

Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature review

scientific article published on 21 February 2019

Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial

artículo científico publicado en 2020

Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials

scientific article published on 01 August 2020

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

artículo científico publicado en 2015

Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study

scientific article published on 11 March 2020

TP53 mutational status and cetuximab benefit in rectal cancer: 5-year results of the EXPERT-C trial

artículo científico publicado en 2014

Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution

scientific article published on 07 September 2019

The Mutational Concordance of Fixed Formalin Paraffin Embedded and Fresh Frozen Gastro-Oesophageal Tumours Using Whole Exome Sequencing

artículo científico publicado en 2021

The genomic landscape of oesophagogastric junctional adenocarcinoma

artículo científico publicado en 2013

The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer

artículo científico publicado en 2004

Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial?

artículo científico publicado en 2011

Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study

artículo científico publicado en 2017

Whole-body diffusion-weighted MRI in lymphoma-comparison of global apparent diffusion coefficient histogram parameters for differentiation of diseased nodes of lymphoma patients from normal lymph nodes of healthy individuals

artículo científico publicado en 2021

Lista de obras de Ian Chau

A very rare complication of subdural haematoma: fibrin-associated diffuse large B-cell lymphoma

ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UK

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study

Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study

Association of quality of life with disease characteristics and treatment outcomes in patients with advanced gastric cancer: Exploratory analysis of RAINBOW and REGARD phase III trials

Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases ⬇️

Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer

Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer.

Evaluating Mesorectal Lymph Nodes in Rectal Cancer Before and After Neoadjuvant Chemoradiation Using Thin-Section T2-Weighted Magnetic Resonance Imaging

Exclusion of Gastrointestinal Cancer Patients With Prior Cancer From Clinical Trials: Is This Justified?

In Reply

Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: A pooled analysis of four randomised trials

Integrative molecular analysis of colorectal cancer and gastric cancer: What have we learnt?

Is front-line checkpoint blockade ATTRACTIVE in advanced gastric cancer?

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer.

Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer

Molecular target: pan-AKT in gastric cancer

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial

Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer

Neoadjuvant chemotherapy alone for early-stage rectal cancer: an evolving paradigm?

Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.

Patupilone in cancer treatment ⬇️

Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-cell Lymphoma

Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature review

Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial

Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study

TP53 mutational status and cetuximab benefit in rectal cancer: 5-year results of the EXPERT-C trial

Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution

The Mutational Concordance of Fixed Formalin Paraffin Embedded and Fresh Frozen Gastro-Oesophageal Tumours Using Whole Exome Sequencing

The genomic landscape of oesophagogastric junctional adenocarcinoma

The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer

Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial?

Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study

Whole-body diffusion-weighted MRI in lymphoma-comparison of global apparent diffusion coefficient histogram parameters for differentiation of diseased nodes of lymphoma patients from normal lymph nodes of healthy individuals